Machine Learning for the Design of Cancer Vaccine Adjuvants
Invention type: Technology
/
Case number: #21680J
The disclosure describes poly(B-thioester) polymers and polymeric nanoparticles, pharmaceutical compositions comprising these materials, their use in the treatment of cancer and infectious disease, and machine learning methods for identifying and selecting them.
Researchers
Robert Langer
/
Netra Kamat
/
Hyunjoon Kim
/
Lewis Scott Jones
/
Daniel Reker
/
Ameya Kirtane
/
Giovanni Traverso
Departments: Office of the Institute Professors, David H Koch Institute for Integrative Cancer Res, Department of Mechanical Engineering
Technology Areas: Artificial Intelligence (AI) and Machine Learning (ML) / Chemicals & Materials: Nanotechnology & Nanomaterials, Polymers / Drug Delivery: Microparticles & Nanoparticles / Therapeutics: Vaccines
Impact Areas: Healthy Living, Uncharted Frontiers
-
poly(beta-thioester) polymers and polymeric nanoparticles
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.